Egyptian Journal of Medical Human Genetics

Table 2 C421 and G34A genotype frequencies in the responder and resistant groups

From: Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients

SNP	Genotype	Responder (%)	Resistant (%)	OR	(95% CI)	P
C421A	CC	33 (75.0)	25 (89.3)	1.00
	CA	11 (25.0)	3 (10.7)	2.78	(0.70–11.02)	0.146
G34A	GG	17 (38.6)	7 (25.0)	1.00
	AG	27 (61.4)	21 (75.0)	1.89	(0.66–5.39)	0.235

Back to article page